Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Shares Issued (2016 - 2025)

Historic Shares Issued for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $353000.0.

  • Lisata Therapeutics' Shares Issued changed N/A to $353000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $358657.0, marking a year-over-year increase of 54045.89%. This contributed to the annual value of $68000.0 for FY2024, which is 7881.62% down from last year.
  • According to the latest figures from Q3 2025, Lisata Therapeutics' Shares Issued is $353000.0.
  • Lisata Therapeutics' 5-year Shares Issued high stood at $353000.0 for Q3 2025, and its period low was -$703000.0 during Q2 2023.
  • In the last 3 years, Lisata Therapeutics' Shares Issued had a median value of $32000.0 in 2024 and averaged -$41191.9.
  • Per our database at Business Quant, Lisata Therapeutics' Shares Issued surged by 10455.19% in 2024 and then plummeted by 85732.19% in 2025.
  • Over the past 3 years, Lisata Therapeutics' Shares Issued (Quarter) stood at $24000.0 in 2023, then skyrocketed by 50.0% to $36000.0 in 2024, then soared by 880.56% to $353000.0 in 2025.
  • Its Shares Issued stands at $353000.0 for Q3 2025, versus -$242343.0 for Q2 2025 and $212000.0 for Q1 2025.